Back | Next |
home / stock / vygr / vygr message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts now | ttottip | investorshub | 04/17/2023 10:06:39 AM |
$VYGR Long and strong lets hope im right | BPETER | investorshub | 04/16/2023 11:41:41 AM |
$VYGR short squeeze signal | TheFinalCD | investorshub | 04/15/2023 7:46:51 PM |
short squeeze | Gary Ray | investorshub | 04/15/2023 6:18:58 PM |
$VYGR Looks pretty positive | ttottip | investorshub | 04/14/2023 3:25:54 PM |
should we be shorting? | Gary Ray | investorshub | 04/14/2023 12:38:53 PM |
$VYGR best news of the day | ttottip | investorshub | 04/13/2023 5:04:53 PM |
$VYGR just the news we needed | Roadtojourney | investorshub | 04/13/2023 2:15:08 PM |
got some short data | ttottip | investorshub | 04/13/2023 1:58:42 PM |
$VYGR Price gaining last trade up | Argus63 | investorshub | 04/13/2023 4:01:17 AM |
oh yeah news for the day | ttottip | investorshub | 04/12/2023 6:08:54 PM |
$VYGR MomentumIts gaining | Gary Ray | investorshub | 04/10/2023 4:05:25 AM |
Nice run on $VYGR $5.68 to $10.77 In 4 | Elgordo84 | investorshub | 01/22/2023 6:59:54 PM |
Entice new guppies. You know how we do :) | Gary Ray | investorshub | 01/10/2023 7:53:48 PM |
8.25 hmmmm | TheFinalCD | investorshub | 01/10/2023 4:28:52 PM |
indeed .....aGREED | TheFinalCD | investorshub | 01/09/2023 7:15:58 PM |
Gap up! Trap that new young blood LOL | Gary Ray | investorshub | 01/09/2023 7:14:44 PM |
$VYGR NEWS https://finance.yahoo.com/news/neurocrine-biosciences-voyager-therape | TheFinalCD | investorshub | 01/09/2023 1:12:13 PM |
Corvette: And yet another stock we agree on. VYGR. I own a lot of it. Have traded it successfully in | Corvette | investorshangout | 12/24/2022 4:18:29 PM |
Its about to get really interesting on this | Elgordo84 | investorshub | 08/25/2022 10:57:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Voyager Therapeutics Inc. Company Name:
VYGR Stock Symbol:
NASDAQ Market:
Voyager Therapeutics Inc. Website:
- Company announces clearance of IND application with FDA for anti-tau antibody VY-TAU01 for the treatment of Alzheimer’s disease; expect to begin single ascending dose trial in the coming weeks - - Development candidates selected for Neurocrine-partnered GBA1 and Friedreich ...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
- Translational potential of TRACER-derived AAV capsids demonstrated by data across multiple species (murine, porcine, multiple NHPs, human cells) and receptor binding - - Preclinical safety and efficacy demonstrated in Alzheimer’s disease and ALS gene therapies; low IV doses pro...